12.67 -0.16(-1.25%)07/03/2024
Stoke Therapeutics Inc (STOK)
Stoke Therapeutics Inc (STOK)
Showing latest 10 records. To view more news, Upgrade to PRO plan with only $1
| Headline | Time (ET) | Source |
|---|---|---|
| Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) | 06/18 16:30 | businesswire.com |
| Stoke Therapeutics' STK-001: A Potential Game-Changer For Dravet Syndrome | 06/14 12:10 | seekingalpha.com |
| Stoke Therapeutics to Present at Upcoming Investor Conferences in June | 06/03 16:30 | businesswire.com |
| Stoke Therapeutics, Inc. (STOK) Reports Q1 Loss, Tops Revenue Estimates | 05/06 09:06 | zacks.com |
| Stoke Therapeutics Reports First Quarter Financial Results and Provides Business Updates | 05/06 07:00 | businesswire.com |
| Earnings Preview: Stoke Therapeutics, Inc. (STOK) Q1 Earnings Expected to Decline | 04/25 11:07 | zacks.com |
| Stoke Therapeutics Appoints Jason Hoitt as Chief Commercial Officer | 04/17 08:00 | businesswire.com |
| Stoke Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference | 04/04 16:30 | businesswire.com |
| Stoke Therapeutics Announces Pricing of Upsized $125 Million Public Offering | 03/27 23:40 | businesswire.com |